ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 4623

$900K Total Retail Price of All Prescriptions

Rank: 193 out of 4623

825 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 825 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 825 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,783 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 626 508 S3 1 3
AMLODIPINE BESYLATE 598 518 2 5
SIMVASTATIN 596 535 3 2
LOVASTATIN 505 487 4 34
OMEPRAZOLE 451 404 5 7
LEVOTHYROXINE SODIUM 418 397 6 1
BENAZEPRIL HCL 388 370 7 70
LISINOPRIL 379 338 8 4
SERTRALINE HCL 317 282 9 26
METFORMIN HCL 316 299 10 6
FUROSEMIDE 309 277 11 8
TRAMADOL HCL 308 283 12 15
METOPROLOL TARTRATE 291 271 13 9
TAMSULOSIN HCL 290 271 14 29
GABAPENTIN 262 216 15 16
POTASSIUM CHLORIDE 230 215 16 14
DONEPEZIL HCL 226 226 17 30
GEMFIBROZIL 223 193 18 94
DILTIAZEM 24HR CD 217 211 19 156
PRAVASTATIN SODIUM 208 199 20 11
DILTIAZEM ER 204 191 21 179
HYDROCHLOROTHIAZIDE 199 193 22 10
ALENDRONATE SODIUM 193 192 23 22
LOSARTAN POTASSIUM 170 170 24 21
ZOLPIDEM TARTRATE 165 147 25 18
WARFARIN SODIUM 164 162 26 24
CLONIDINE HCL 155 138 27 40
CLOPIDOGREL 154 144 28 31
DILTIAZEM 24HR ER 151 148 29 281
ATENOLOL 142 127 30 28
BENAZEPRIL-HYDROCHLOROTHIAZIDE 139 126 31 212
NEXIUM 134 99 32 17
ALLOPURINOL 130 110 33 37
ZETIA 127 111 34 92
VERAPAMIL ER 126 111 35 96
TRAZODONE HCL 122 94 36 42
CARVEDILOL 120 96 37 25
CIPROFLOXACIN HCL 117 109 38 43
AMLODIPINE BESYLATE-BENAZEPRIL 117 105 38 55
CRESTOR 116 105 40 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 100 41 19
ATORVASTATIN CALCIUM 108 97 42 12
PREDNISONE 101 94 43 50
METFORMIN HCL ER 100 66 44 51
DIOVAN HCT 99 93 45 67
PLAVIX 98 87 46 45
FLUTICASONE PROPIONATE 95 82 47 32
FINASTERIDE 92 91 48 109
MECLIZINE HCL 92 83 48 125
GLIMEPIRIDE 88 78 50 38
LOSARTAN-HYDROCHLOROTHIAZIDE 87 82 51 46
SYNTHROID 86 86 52 73
TRIAMTERENE-HCTZ 85 85 53 80
NAMENDA 83 83 54 36
BENICAR 80 80 55 168
METOPROLOL SUCCINATE 79 66 56 13
TERAZOSIN HCL 78 76 57 143
PAROXETINE HCL 73 53 58 78
SPIRIVA 73 73 58 79
HYDRALAZINE HCL 70 63 60 99
PROAIR HFA 69 63 61 64
ACTONEL 68 68 62 165
OXYBUTYNIN CHLORIDE 68 64 62 120
CYCLOBENZAPRINE HCL 68 59 R 62 53
VYTORIN 67 54 65 170
PREMARIN 66 64 R 66 140
ONGLYZA 65 65 67 192
CITALOPRAM HBR 63 60 68 23
DIGOXIN 62 62 69 58
FENTANYL 60 43 S2 70 118
PROPRANOLOL HCL 60 60 70 169
CYMBALTA 59 32 72 48
ESCITALOPRAM OXALATE 57 50 73 75
DIOVAN 55 55 74 39
JANUVIA 55 46 74 52
INSULIN SYRINGE 54 37 76 85
TRILIPIX 53 36 77 150
WELCHOL 53 53 77 276
AMITRIPTYLINE HCL 52 52 R 79 69
MELOXICAM 50 49 80 27
GLYBURIDE 50 35 R 80 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.